Evidence map›Paper›PMID 40290512›Full record

ReviewTherapeutic advances in drug safety2025

Mydriasis mediated by local anesthetics: an unexpected adverse event or new therapeutic indication?

Homero Contreras-Salinas, Janet Cristina Vázquez-Beltrán, María Soledad Romero-López, Oscar Olvera-Montaño, Lourdes Yolotzin Rodríguez-Herrera

Abstract readReview
In one paragraph

Review in Therapeutic advances in drug safety, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Homero Contreras-SalinasPharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Av. Paseo del Norte 5255, Zapopan, Jalisco 45010, México.ORCID https://orcid.org/0000-0001-9918-2024
Janet Cristina Vázquez-BeltránPharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, México.ORCID https://orcid.org/0000-0001-6686-0183
María Soledad Romero-LópezPharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, México.ORCID https://orcid.org/0009-0008-7170-2188
Oscar Olvera-MontañoPharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, México.ORCID https://orcid.org/0000-0003-2717-349X
Lourdes Yolotzin Rodríguez-HerreraPharmacovigilance Department, Laboratorios Sophia, S.A. de C.V., Zapopan, Jalisco, México.ORCID https://orcid.org/0000-0002-4424-4213

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing off-label use of medications needs a robust pharmacovigilance system. This is particularly crucial given the abundance of scientific data that can be harnessed to ensure a product's safety. Our review focuses on the off-label use of local anesthetics, a common practice in topical and intracameral applications. However, the occurrence of mydriasis, as indicated in the monographs/summaries of product characteristics, is an unexpected adverse event. Our aim is to provide a comprehensive understanding of mydriasis caused by local anesthetics, both as an unexpected adverse event and as an off-label use, to reinforce the importance of pharmacovigilance practices. We conducted a comprehensive search in Medline/PubMed and Google Scholar from two distinct perspectives: examining the occurrence of mydriasis with the use of local anesthetic as an adverse event and as an off-label use. Our search yielded 14 articles that reported mydriasis as an unexpected adverse event with the use of anesthetics, with dental procedures being a significant contributor to this type of event. Also, we identified eight articles that explored the off-label use of local anesthetics to induce mydriasis, with the most common method of drug administration being intracameral injection. These findings underscore the importance of our research in understanding the unexpected adverse event of mydriasis and the potential for off-label use of local anesthetics. They also highlight the need for continued involvement and vigilance in this area, as our understanding of these phenomena continues to evolve and further investigation is crucial. The use of local anesthetics for mydriasis holds significant promise, particularly in ophthalmological surgeries. This approach could potentially mitigate the adverse events associated with conventional mydriatics, offering a more efficient and safer alternative. Furthermore, using a single medication for akinesia, anesthesia, and mydriasis could significantly enhance the efficiency and convenience of surgical procedures. On the other hand, it is crucial to extend the knowledge of the mydriasis-anesthesia association through risk minimization activities (e.g., the inclusion of monographs/summary of product characteristics) to communicate the risk of mydriasis with the use of local anesthetics.

Indexed as

adverse eventciliary ganglionlocal anestheticsmydriasisoff-label use

Identifiers

PMID40290512
PMCPMC12033668

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.